rs12470652
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000233.4(LHCGR):āc.872A>Gā(p.Asn291Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0477 in 1,591,022 control chromosomes in the GnomAD database, including 2,122 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_000233.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHCGR | NM_000233.4 | c.872A>G | p.Asn291Ser | missense_variant | 10/11 | ENST00000294954.12 | NP_000224.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHCGR | ENST00000294954.12 | c.872A>G | p.Asn291Ser | missense_variant | 10/11 | 1 | NM_000233.4 | ENSP00000294954.6 | ||
ENSG00000279956 | ENST00000602369.3 | n.*145A>G | non_coding_transcript_exon_variant | 9/13 | 5 | ENSP00000473498.1 | ||||
ENSG00000279956 | ENST00000602369.3 | n.*145A>G | 3_prime_UTR_variant | 9/13 | 5 | ENSP00000473498.1 |
Frequencies
GnomAD3 genomes AF: 0.0375 AC: 5707AN: 152168Hom.: 139 Cov.: 33
GnomAD3 exomes AF: 0.0380 AC: 8953AN: 235680Hom.: 233 AF XY: 0.0386 AC XY: 4897AN XY: 126870
GnomAD4 exome AF: 0.0488 AC: 70217AN: 1438736Hom.: 1983 Cov.: 28 AF XY: 0.0481 AC XY: 34435AN XY: 715502
GnomAD4 genome AF: 0.0375 AC: 5705AN: 152286Hom.: 139 Cov.: 33 AF XY: 0.0364 AC XY: 2711AN XY: 74458
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hypergonadotropic hypogonadism Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Leydig cell agenesis Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Gonadotropin-independent familial sexual precocity Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at